• Mashup Score: 0
    IPIG 2025 | VJHemOnc - 1 day(s) ago

    The 2nd International PNH Interest Group (IPIG) Conference is taking place in Paris, France, on May 15-16, 2025. This meeting will bring together leading experts in the field of PNH to share the latest research, advancements, and insights. The 2nd International PNH Interest Group (IPIG) Conference is taking place in Paris, France, on May 15-16, 2025. This meeting will bring together leading experts in the field of PNH to share the latest research, advancements, and insights. We use cookies to provide the

    Tweet Tweets with this article
    • Wrapping up our first IPIG meeting by speaking to @AustinKulasekar โ€“ this interview is not one to be missed!๐ŸŽฅ We've had some fantastic conversations with PNH experts today, and we've already started sharing them on our site ๐Ÿ‘‰https://t.co/OJLIzhs6Qk There's lots more to come https://t.co/5mMhHTllzX

  • Mashup Score: 0

    In this episode of the VJHemOnc podcast you will hear from Akshay Sharma, MBBS, MSc, St. Jude Childrenโ€™s Research Hospital,…

    Tweet Tweets with this article
    • Will gene therapy transform the future of #SickleCellDisease care?๐Ÿฉธ๐Ÿงฌ We've just published a podcast episode in which @AkshaySharmaMD provides valuable insights into this therapeutic approach. Donโ€™t miss it! ๐ŸŽง๐ŸŽ™๏ธ Listen here: ๐Ÿ‘‰ https://t.co/ZNeFZJpDwA #Hematology https://t.co/CBx2M2c0Be

  • Mashup Score: 2

    We’re bringing your questions straight to leading hematology experts during our Ask the Expert sessions, filmed from the EHA 2025 Congress, at the VJHemOnc booth (B.01). Submit the questions youโ€™d like answered on key topics in hematology. Selected submissions will be answered on camera and featured across VJHemOncโ€™s platforms.

    Tweet Tweets with this article
    • We're bringing your questions straight to leading #HemOnc experts during our Ask the Expert sessions, filmed at our #EHA2025 booth๐Ÿ“๐ŸŽฅ๐Ÿฉธ Barbara Eichhorst @DrRakeshPopat & @AnnaSureda5 To submit a question reply here, send us a DM or fill in this form ๐Ÿ‘‰ https://t.co/7gi4ikVt2R https://t.co/R7pw0zSxHm

  • Mashup Score: 0

    Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, comments on the current state of next-generation CAR constructs in multiple myeloma (MM), highlighting some constructs she believes hold promise for treating this malignancy. Several dual-targeting CAR strategies are being investigated to improve upon the outcomes achieved with currently available CAR T-cell products. Dr Raje also mentions anitocabtagene autoleucel (anito-cel), an autologous anti-BCMA CAR T-cell therapy with a novel synthetic D-domain binder, which is being investigated in the Phase III iMMagine-3 (NCT06413498) clinical trial. This interview took place at the 11th World Congress on Controversies in Multiple Myeloma (COMy) congress in Paris, France. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

    Tweet Tweets with this article
    • Which next-generation CAR constructs hold promise for treating #MultipleMyeloma? @NoopurRajeMD (@MGHCancerCenter) gave an overview of this in her talk at #COMy2025, & we were lucky enough to catch up with her to learn more! Watch here: ๐Ÿ‘‰ https://t.co/YfZBgGMP32 #MMSM #HemOnc

  • Mashup Score: 0

    Jens Panse, MD, Aachen University Hospital, Aachen, Germany, discusses the complexities of switching patients with paroxysmal nocturnal hemoglobinuria (PNH) from C5 inhibitors to proximal complement inhibitors. Dr Panse emphasizes the importance of personalized medicine when deciding which patients might benefit from a switch, particularly after 12 months on C5 inhibition. This interview took place at the 2nd International PNH Interest Group (IPIG) Conference in Paris, France. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

    Tweet Tweets with this article
    • Last week, in a session at #IPIG2025, Jens Panse of โฆ@UniklinikAachen discussed the complexities of switching patients with PNH from C5 inhibitors to proximal complement inhibitors. Hear what he had to say: ๐Ÿ‘‰ https://t.co/k100uJ644G ๐Ÿ‘ˆ #Hematology #PNH #RareDisease

  • Mashup Score: 13
    COMy 2025 | VJHemOnc - 2 day(s) ago

    The 11th World Congress on Controversies in Multiple Myeloma (COMy) took place on May 15-18, 2025, in Paris, France. Leading researchers congregated at this meeting to discuss the latest advances in the scientific understanding and clinical treatment of multiple myeloma. The 11th World Congress on Controversies in Multiple Myeloma (COMy) took place on May 15-18, 2025, in Paris, France. Leading researchers congregated at this meeting to discuss the latest advances in the scientific understanding and

    Tweet Tweets with this article
    • We wanted to say a big thank you to the organizers of #COMy2025 for having us onsite last week!๐Ÿ˜„ As always, it was a pleasure to attend and to be official media partners for the event.๐ŸŽฅ๐Ÿฉธ Explore our exclusive coverage here: ๐Ÿ‘‰ https://t.co/u8X7mYAVx8 #MMSM @COMyCongress https://t.co/EskB8JXeBP

  • Mashup Score: 9

    Join us to watch leading MM experts present summaries on the most significant abstracts from EHA 2025 followed by interactive panel discussions debating current clinical issues. Chaired by Dr Faith Davies with co-moderators Dr Charlotte Pawlyn and Dr Ciara Freeman. Webinar attendees will be given the opportunity to send in their questions where they will be answered during the live panel discussions. *Please note* This webinar is for HCPs and allied health professionals only. Your application to attend will be reviewed and confirmed by VJHemOnc.

    Tweet Tweets with this article
    • Catch up on the latest breakthroughs in #HemOnc with our expert-led Post-#EHA2025 Highlights webinars ๐Ÿ“ฃ๐Ÿ’ป๐Ÿ“@EHA_Hematology The #Myeloma session will be chaired by @FaithEDavies1 & moderated by @_DrCP & @freemanlciaraMD ๐Ÿ”— REGISTER ๐Ÿ‘‰ https://t.co/5fzCkyqwUa https://t.co/zgSuZlflFj